Chronic myelocytic leukemia (CML) is the malignant clone disease which occurs in a haematopoietic stem cell.
慢性粒细胞白血病CML是造血干细胞的恶性克隆增生性疾病。
This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant (HSCT).
这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。
Severe aplastic anemia can be cured by haematopoietic stem cell transplantation. Synegenic HSCT is the best choice for severe aplastic anemia and chronic aplastic anemia.
造血干细胞移植是治愈重型再障的主要手段，同基因造血干细胞移植也适合慢性再障。
The nursing factors are detected which infect allogeneic peripheral blood haematopoietic stem cell infusion in ABO-major incompatible transplantation or ABO-minor incompatible transplantation.
探讨了护理因素对异基因造血干细胞移植中abo血型主要不合和次要不合的干细胞输注的影响。
Conclusion The polymorphism of HLA-A, B, DRB1 are very multiplicity. It is not too difficult for the leukemic patients to find appropriate donors of haematopoietic stem cell transplantation in Hunan.
结论湖南人群的HLA-A、B、DRB1位点等位基因具有复杂的多态性，中国各地常见的基因均有分布，白血病患者在湖南不难找到合适的造血干细胞供者。
Conclusion The polymorphism of HLA-A, B, DRB1 are very multiplicity. It is not too difficult for the leukemic patients to find appropriate donors of haematopoietic stem cell transplantation in Hunan.
结论湖南人群的HLA-A、B、DRB1位点等位基因具有复杂的多态性，中国各地常见的基因均有分布，白血病患者在湖南不难找到合适的造血干细胞供者。
应用推荐